GoodRx Holdings, Inc. Class A Common Stock (GDRX)
NASDAQ · Healthcare
GoodRx Holdings, Inc. Class A Common Stock Total Liabilities 2020–2025
GoodRx Holdings, Inc. Class A Common Stock annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- GoodRx Holdings, Inc. Class A Common Stock total liabilities as of December 31, 2025: 787.8M, a 18.75% increase year-over-year.
- GoodRx Holdings, Inc. Class A Common Stock total liabilities for 2025 were 787.8M, a 18.75% increase from 2024.
- GoodRx Holdings, Inc. Class A Common Stock total liabilities for 2024 were 663.4M, a 19.77% decrease from 2023.
- GoodRx Holdings, Inc. Class A Common Stock total liabilities for 2023 were 826.8M, a 4.69% increase from 2022.
- GoodRx Holdings, Inc. Class A Common Stock total liabilities for 2022 were 789.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| GoodRx Holdings, Inc. Class A Common Stock Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $788 |
| 2024 | $663 |
| 2023 | $827 |
| 2022 | $790 |
| 2021 | $776 |
| 2020 | $759 |
GoodRx Holdings, Inc. Class A Common Stock Total Liabilities — FAQ
GoodRx Holdings, Inc. Class A Common Stock (GDRX) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GDRX's total liabilities history?
The chart and table above show GoodRx Holdings, Inc. Class A Common Stock's total liabilities by year and by quarter, including the growth rate.